Plasma 16 beta-hydroxydehydroepiandrosterone in normal and pathological conditions in man

Area of Science:

• Endocrinology
• Steroid Biochemistry

Background:

• 16beta-hydroxydehydroepiandrosterone (16 beta-OH-DHEA) is a steroid hormone with an incompletely understood physiological role.
• Understanding its secretion and regulation is crucial for diagnosing and managing various endocrine and metabolic conditions.

Purpose of the Study:

• To quantify plasma 16 beta-OH-DHEA levels in normal individuals across different age groups.
• To investigate the dynamic changes in 16 beta-OH-DHEA in response to hormonal stimulation and suppression.
• To determine the primary sites of 16 beta-OH-DHEA secretion and its association with specific pathological states.

Main Methods:

• Radioimmunoassay (RIA) was employed to measure plasma concentrations of 16 beta-OH-DHEA.
• Hormonal stimulation (ACTH, gonadal) and suppression (dexamethasone, gonadal) tests were performed.
• Analysis of steroid levels in adrenal, hepatic, and systemic venous blood samples.

Main Results:

• Plasma 16 beta-OH-DHEA levels exhibited a distinct pattern, increasing during adolescence and declining with age.
• Significant changes in 16 beta-OH-DHEA were observed following ACTH stimulation, dexamethasone suppression, gonadal suppression, and gonadal stimulation.
• Elevated 16 beta-OH-DHEA was noted in normal pregnancy, toxemia, Cushing's disease, ectopic ACTH syndrome, and congenital adrenal hyperplasia, but not in low-renin hypertension.
• Higher concentrations in adrenal venous blood suggested adrenal cortex secretion, with possible gonadal contribution.

Conclusions:

• Plasma 16 beta-OH-DHEA levels demonstrate significant age-related variations and are responsive to hormonal regulation.
• The adrenal cortex is a primary source of 16 beta-OH-DHEA secretion, with potential contribution from the gonads.
• Elevated 16 beta-OH-DHEA is a potential biomarker for conditions such as pregnancy complications and specific adrenal disorders.